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Abstract
Background: Cardiovascular risk assessment is usually based on traditional risk factors and risk assessment algorithms.
However, a number of risk markers that might provide additional predictive power have been identified. Endothelial
function determined by digital reactive hyperemia peripheral arterial tonometry (RH-PAT) and carotid artery intima-
media thickness (IMT) have both been proposed as surrogate markers for coronary artery disease (CAD). We aimed to
examine the ability of RH-PAT and IMT to predict coronary computed tomography angiography (CTA) plaque burden
in clinically healthy subjects.
Methods: Fifty-eight clinically healthy volunteers (50–73 years old) underwent testing for RH-PAT and IMT as well as
coronary CTA, including coronary artery calcium (CAC) scoring. Coronary CTA was analyzed with respect to any
atheromatous plaques, stenotic as well as non-stenotic. The Mann–Whitney U-test was used to compare the
groups with and without CAD and the Spearman test was used to test for correlation between variables.
Results: Twenty-five (43 %) subjects had normal coronary arteries, without any signs of atherosclerosis. The median
(range) number of diseased segments was 1 (0–10), RH-PAT index 2.2 (1.4-4.9), IMT 0.70 (0.49-0.99) mm and CAC 4
(0–1882). There was no association between presence or extent of CAD and RH-PAT index (Spearman correlation
coefficient rs = 0.13) or IMT (rs = 0.098). As expected, CAC was strongly correlated to presence and extent of CAD
by coronary CTA (rs =0.86; p < 0.0001).
Conclusions: Neither evaluation of endothelial function by RH-PAT nor assessment of carotid artery IMT can reliably
be used to predict coronary CTA plaque burden in clinically healthy subjects.
Keywords: CAD, Coronary artery disease, RH-PAT, PAT, Endothelial function, IMT, CIMT, Intima-media thickness,
Coronary CTA, Coronary computed tomography angiography
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Background
Cardiovascular risk assessment, which is of great importance
for guiding early preventive interventions and treatment, is
usually based on traditional risk factors and risk assessment
algorithms, such as the Framingham, the SCORE or the
Reynolds risk scores [1–3]. In the search for easily accessible
non-invasive tests that might provide additional pre-
dictive power, a number of novel risk markers have been
identified [4].
Endothelial dysfunction is an early marker of athero-
thrombotic disease, being closely related to cardiovascu-
lar risk factors and also predicting cardiovascular events
in patients with or without established cardiovascular
disease [5, 6]. Since endothelial dysfunction is a systemic
disorder, measurement of peripheral endothelial function
can be used as a surrogate for coronary endothelial func-
tion [7, 8]. A quite recently developed method for assessing
peripheral endothelial function is measuring digital reactive
hyperemia peripheral arterial tonometry (RH-PAT), which
has the advantage of being an easily accessible, largely
operator-independent and highly reproducible method
[9, 10]. A recent study demonstrated an association be-
tween endothelial function determined by RH-PAT and
several cardio-metabolic risk factors, in particular male
sex, overweight, smoking and low levels of HDL choles-
terol [11].
A well established non-invasive surrogate marker for
CAD is ultrasound measurement of the carotid artery
intima-media thickness (IMT), which has proven to be
associated with prevalent cardiovascular disease and to
predict cardiovascular events [12, 13]. More recent studies
however have challenged this role of IMT [14].
Numerous studies have shown that coronary artery cal-
cium (CAC) scoring using cardiac computed tomography
(CT) improves prediction of coronary heart disease events
beyond traditional risk factors and risk scores [4, 15].
Coronary CT angiography (CTA) has evolved substan-
tially during the last few years, and has been shown to
entail very good accuracy when it comes to diagnosing
stenoses of the coronary arteries as compared to conven-
tional coronary angiography [16]. In addition to showing
the lumen of the coronary arteries, coronary CTA also
permits visualization of the vessel wall and thus detection
of atherosclerotic plaques even when they do not give rise
to stenoses. Accordingly, coronary CTA has also been
shown to be highly sensitive in detecting atherosclerotic
plaques of the coronary arteries when compared to intra-
vascular ultrasound [17]. A number of recent studies have
demonstrated a prognostic value of coronary CTA for risk
prediction of adverse cardiovascular events in symtomatic
and asymtomatic patients [18–20].
Even though measurements of peripheral endothelial
function and IMT are supposed to reflect the presence
and extent of CAD, only a few studies have compared
these measures with plaque burden of the coronary ar-
teries, as determined by coronary CTA [21]. Even fewer
have focused on clinically healthy subjects, with predom-
inantly low to intermediate risk profiles [22].
To clarify whether these non-invasive tests can reliably
be used to predict coronary plaque burden in clinically
healthy subjects, we studied the correlation of endothelial
function and IMT respectively with plaque burden, as
assessed by coronary CTA. For comparison we also
studied the ability of CAC to predict plaque burden in
the same group.
Methods
The study conforms to the principles of the Declaration
of Helsinki and was approved by the Regional Ethical
Review Board in Stockholm and by the Radiation Protec-
tion Committee of the Karolinska University Hospital.
Written informed consent was obtained from all study
participants.
Study group
The study group consisted of fifty-eight healthy volunteers
between 50 and 73 years old, who were recruited in the
Stockholm metropolitan area between June 2007 and May
2011, through a registry comprising all Stockholm resi-
dents. If they were willing to participate and had no previ-
ously known cardiovascular disease they underwent an
exercise stress test, and if the test was normal they were
invited to take part in the study. Exclusion criteria were
previous adverse reaction to iodinated contrast media,
renal dysfunction and arrhythmia (jeopardizing the diag-
nostic quality of the CT scan).
Endothelial function assessment
Endothelial function was assessed using the digital react-
ive hyperemia peripheral arterial tonometry (RH-PAT)
device EndoPAT (Itamar Medical Ltd., Caesarea, Israel),
according to the method described in detail by Hamburg
et al [23]. The method involves measuring pulse wave
amplitude of the fingertip (namely the PAT signal), by
use of a fingertip probe, at rest and after a 5-minute oc-
clusion of the brachial artery, using a standard blood
pressure cuff inflated to supra-systolic pressure. When the
cuff is deflated, the surge of blood causes an endothelium-
dependent flow mediated dilatation leading to reactive
hyperemia and an increase in the PAT signal amplitude. A
fingertip probe is also placed on the index finger of the
contra lateral side for internal control. As a measure of re-
active hyperemia the reactive hyperemia index (RHI) was
calculated, using dedicated software, as the ratio between
the post-occlusion and the pre-occlusion PAT signal amp-
litude divided by the corresponding ratio of the contra
lateral side, to adjust for any spontaneous or systemic
alterations of vascular tone. The test was performed in
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a thermo-neutral and quiet surrounding, after fasting
and avoiding pre-test smoking/ snuff or consumption
of caffeine.
Carotid artery ultrasound
Two-dimensional images of the left and right common
carotid artery (CCA) were acquired using an ultrasound
scanner equipped with a 12 MHz transducer (Vivid 7,
General Electric Company, Horten, Norway). From each
CCA a long-axis cine loop of three beats and three
diastolic images at the time of the electrocardiographic
R-wave were digitally stored for off-line analysis. The
intima-media thickness (IMT) of the CCA far wall was
measured in three diastolic images using semi-automatic
IMT analysis software (General Electric Company). A
10 mm region of interest (ROI) was manually placed start-
ing 1 cm proximal to the carotid bulb. The borders be-
tween the intima-media of the far wall and the lumen or
the adventitia respectively, were identified automatically.
In case of suboptimal tracking, the ROI was adjusted or
another diastolic frame was chosen. Manual correction
was not performed. The left and right IMT results were
calculated as the mean of three semi-automatic measure-
ments, and finally the average of these two results was ob-
tained. All examinations were performed and interpreted
by the same experienced ultrasonographer, who did not
have access to the coronary CTA findings.
Coronary CTA data acquisition and analysis
Examinations were performed on a 64-slice CT scanner
(LightSpeed VCT XT; GE Healthcare, Milwaukee, WI,
USA). A prospectively ECG-triggered scan protocol was
used: detector configuration 64 x 0.625 mm, rotation time
350 ms, tube potential 120 kV, tube current 450–650 mA
(according to patient size), padding 0–200 ms (depending
on heart rate variability). The contrast agent used was
iodixanol 320 mg I/ml (Visipaque, GE Healthcare,
Stockholm, Sweden), which was administered using a
dual-head injector (Medrad, Stellant Dual Head Injector,
Pittsburgh, PA, USA) and a triple-phase protocol. The
contrast agent was individually dosed, based on body
weight (400 mg I/kg, 75–100 ml iodixanol) with a fixed
injection time (15 s), resulting in an injection rate of
5–7 ml/s. This was followed by a 50 ml mixture of
40 % iodixanol and 60 % saline and finally by a 50 ml saline
chaser. Bolus tracking software was used (SmartPrep, GE
Healthcare, Milwaukee, WI, USA) in order to synchronize
image acquisition with optimal contrast opacification of
the coronary arteries. In the absence of contraindications
and depending on the initial heart rate, patients received
metoprolol (25–100 mg) per os prior to the examination.
Patients also received sublingual nitroglycerine (0.4 mg)
4 minutes before the scan.
The coronary CTA exam was analyzed independently
by three readers (two experienced readers with level 2
and one reader with level 1 according to ACCF/AHA
levels of competence) [24], who were blinded to all clin-
ical information as well as to the results of endothelial
function and IMT testing. A subsequent joint reading
was performed and a consensus reached. Coronary
CTA data analysis was performed using the CardIQ
Xpress software on the Advantage Workstation 4.4 (GE
Healthcare, Milwaukee, WI, USA). Axial source images,
multiplanar and curved multiplanar reformats as well
as thin-slab maximum intensity projections were used.
The optimal image display setting for lumen and plaque
assessment was chosen on an individual basis, but in
general at a window width of 800–1000 HU and a level
of 100–200 HU. Coronary arteries were subdivided into
17 segments, according to the modified American Heart
Association classification [25]. Initially, each segment
was assessed regarding image quality and evaluability.
Segments were considered non-evaluable if artifacts pre-
vented reliable assessment of the lumen or the vessel wall
(e. g. due to motion, image noise or heavy calcification).
Secondly, each segment was visually evaluated with regard
to the presence of plaques and stenoses. Lesions were
quantified for stenosis by visual estimation, comparing the
minimal lumen of the stenotic area with the lumen of the
adjacent proximal unaffected segment, and expressed in
terms of diameter stenosis: <50 % (non-obstructive CAD)
or ≥50 % (obstructive CAD).
Coronary artery calcium score
To obtain the CAC score, a non-enhanced scan was per-
formed, using a prospectively ECG-triggered scan protocol:
detector configuration 64 x 0.625 mm, rotation time
350 ms, tube potential 120 kV, tube current 200 mA.
The CAC score was calculated using semi-automatic
software (SmartScore 4.0, GE Healthcare, Milwaukee, WI,
USA) on the Advantage Workstation 4.4 (GE Healthcare,
Milwaukee, WI, USA). The total calcium burden of the
coronary arteries was reported in terms of AJ-130 score,
based on the scoring algorithm of Agatston et al [26].
Statistical methods and data management
Initially, data were characterized using descriptive statis-
tics and graphically assessed for normal distribution. Con-
tinuous variables are presented as mean ± SD or median
(range). Since the variables to be compared were not nor-
mally distributed, non-parametric tests were used. Hence,
statistical comparisons in order to test differences between
two arbitrary independent groups were made by use of
the Mann–Whitney U-test. The Spearman test was used
to test correlation between variables. All analyses were
carried out by use of the SAS system (The SAS system for
Brolin et al. BMC Cardiovascular Disorders  (2015) 15:63 Page 3 of 7
Windows 9.3, SAS Institute Inc., Cary, NC, USA.) and the
5 % level of significance was considered.
A post-hoc power analysis yielded a power of 0.68 to
show a 20 percent decrease in RHI in subjects with CAD
compared to those without CAD, given the 5 % level of
significance.
Results
All 58 study participants underwent coronary CTA, with
subsequent plaque burden analysis, as well as testing for
peripheral endothelial function by means of RH-PAT. A
non-enhanced cardiac CT scan for CAC scoring was ob-
tained in 51 persons. Ultrasound of the carotid arteries
and calculation of IMT was successfully performed in 57
study participants.
Baseline characteristics of the study group are presented
in Table 1. Importantly, only three subjects were on lipid-
lowering medication. Risk assessment was performed
according to the Framingham risk algorithm [1]. Thirty-
one participants (53 %) had a 10-year risk of 10 % or less,
whilst 18 (31 %) had a 10-20 % risk and 9 (16 %) had an
elevated risk exceeding 20 %.
When analyzing the coronary CTA, only 2 % of coron-
ary segments were considered non-evaluable. Coronary
CTA showed normal coronary arteries, i e neither ob-
structive nor non-obstructive CAD, in 25 (43 %) study
participants. Thirty-two (55 %) persons had non-ob-
structive CAD and only one person (2 %) had obstructive
CAD. The RHI in the study group ranged from 1.4 to 4.9,
with a median of 2.2. Carotid artery IMT ranged from
0.49 mm to 0.99 mm, with a median of 0.70 mm. Even
though the main focus of the ultrasound examination was
the common carotid artery, there were three subjects with
evident plaques in the carotid bulb. All of these subjects
had CAD by coronary CTA. The CAC score ranged from
0 to 1882, with a median of 4.
When comparing the groups with and without evi-
dence of CAD by coronary CTA, no statistically signifi-
cant differences were found concerning RHI or IMT.
Nor was there any correlation between the number of
diseased segments on coronary CTA and RHI (Spearman
correlation coefficient 0.13) or IMT (Spearman correlation
coefficient 0.098). Not surprisingly, there was a statistically
significant difference in CAC scores when comparing the
groups with and without CAD demonstrated by coronary
CTA (p < 0.0001). Similarly, there was a strong correlation
between the CAC score and the number of diseased cor-
onary segments (Spearman correlation coefficient 0.86,
p < 0.0001). Results are shown in Table 2 and Fig. 1. Still,
among persons with a 0 CAC score 3 (14 %) had evidence
of CAD by coronary CTA.
Discussion
The most important findings were that peripheral endo-
thelial function by the RH-PAT method and IMT did not
differ significantly between the groups with and without
evidence of CAD by coronary CTA, and that there was no
correlation between RHI or IMT and number of diseased
coronary artery segments. Not surprisingly, the CAC score
was significantly higher in the group with CAD compared
to the group without, and there was a strong association
between CAC and the number of diseased segments.
However, a 0 CAC score did not exclude the presence of
atherosclerotic plaques on coronary CTA.
To the best of our knowledge, this is the first publi-
cation comparing endothelial function by the RH-PAT
method with coronary CTA plaque burden. It is one of
the few studies comparing IMT with plaque burden, as
determined by coronary CTA, and is unusual in study-
ing a mainly female group with a predominantly low to
intermediate cardiovascular risk profile.
Matsuzawa et al. studied 140 women with chest pain,
who underwent endothelial function testing by RH-PAT
as well as conventional coronary angiography and demon-
strated a significantly worse endothelial function in patients
with obstructive and non-obstructive CAD compared to
Table 1 Characteristics of study group (n = 58)
Age (years) 61 ± 6
Female 39 (67 %)
Present smoking 2 (3 %)
Prior smoking 23 (40 %)
Family history of CAD 14 (24 %)
Diabetes mellitus 0 (0 %)
Treated hypertension 6 (10 %)
Treated hyperlipidemia 3 (5 %)
BMI (kg/m2) 25.8 ± 3
SBP 129 ± 13
DBP 80 ± 6
Total cholesterol (mmol/l) 5.6 ± 0.8
LDL (mmol/l) 3.7 ± 0.8
HDL (mmol/l) 1.5 ± 0.4
Triglycerides (mmol/l) 1.0 ± 0.4
Abbreviations: BMI, body mass index; CAD, coronary artery disease; SBP,
systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density
lipoprotein; HDL, high-density lipoprotein; SD, standard deviation. Data are
presented as mean ± SD or absolute value (percentage)
Table 2 Comparison between groups with and without CAD
(as determined by coronary CTA)
No CAD n = 25 CAD n = 33 P
RHI 2.2 (1.4-4.9) 2.1 (1.4-3.6) ns
IMT (mm) 0.70 (0.53-0.99) 0.71 (0.49-0.99) ns
CAC 0 (0–4) 36 (0–1882) <0.0001
Abbreviations: CAD, coronary artery disease; CTA, computed tomography
angiography; RHI, reactive hyperemia index; IMT, carotid artery intima-media
thickness; CAC, coronary artery calcium score; ns, non significant. Values are
presented as median (range)
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patients with no CAD [27]. The RHI was markedly worse
in the patients with CAD of that study compared to the
RHI of the patients with CAD of the present study. This
difference might reflect a significantly greater risk factor
burden of the patients of the previous study. The fact that
the present study analyzed CAD by coronary CTA instead
of using conventional coronary angiography might also
have affected the results. Since coronary CTA permits
visualization of non-stenotic lesions that might not be
visible on conventional coronary angiography, more pa-
tients with limited disease are likely to end up classified
as having CAD when coronary CTA is used instead of
conventional coronary angiography. Rohani et al., on the
contrary, reported a lack of association between endothe-
lial function, expressed in terms of flow mediated dilation
of the brachial artery, and the angiographic extent of
coronary stenoses in patients with severe CAD [28]. A
possible implication of their findings might be that
endothelial function testing is of limited value for pa-
tients with pre-existing severe CAD. It has indeed been
suggested that endothelial function testing, and in par-
ticular testing involving the microvasculature as is the
case for the RH-PAT method, might be more suitable
for subjects with a low prevalence of risk factors [29].
Our findings for the present study group, however, do
not support this hypothesis.
With respect to the lack of association between IMT
and the presence and extent of CAD, our findings differ
from those of some previous studies [21, 30, 31]. These
studies, however, have mainly focused on patient groups
with a more pronounced risk profile and with more
severe CAD, as determined by cardiac CT or by conven-
tional coronary angiography, compared to the present
study group. Our findings are partly supported by a re-
cent study by Schroeder et al., who found no significant
relationship between carotid artery ultrasound findings
and coronary CTA plaque burden [22]. They did however
demonstrate a higher sensitivity of carotid ultrasound
compared to CAC for coronary CTA plaque burden.
Their study focused on asymtomatic patients referred
for risk stratification, with a cardiovascular risk profile
and a prevalence of CAD similar to that of the present
study. The increasing evidence that IMT of the common
carotid artery may not be a good marker for coronary
atherosclerosis also supports the results of the present
study [14].
The finding of a strong correlation between CAC and
the presence and extent of CAD as determined by cor-
onary CTA is not surprising, since the two measures
correspond to two aspects of the atherosclerotic process
of the coronary vascular bed.
An important limitation of the present study is the
limited sample size. Thus, lack of significant differences
and correlation may be caused by lack of power to de-
tect such differences. Since no correlations were found,
additional statistical analyses to determine sensitivity, spe-
cificity and predictive values were not performed. The
study group mainly reflects a northern European ethnic
group, which might affect generalizability. Since the study
group was recruited among clinically healthy subjects, the




Fig. 1 Correlation between number of diseased segments, as
determined by coronary CTA, and RHI (a), IMT (b) and CAC (c). The
larger point (0, 0) in (c) corresponds to 23 subjects. Abbreviations:
CTA, computed tomography angiography; RHI, reactive hyperemia
index; IMT, intima-media thickness; CAC, coronary artery calcium
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there were no patients with for instance diabetes mellitus
or HIV infection. This might also affect generalizability,
due to differences in plaque burden in specific patient
groups. For instance, a greater proportion of non-calcified
plaques was demonstrated in HIV patients compared to
healthy subjects [32]. The validity of the results of this
study is dependent on the validity of the methods used.
Although 64-detector coronary CTA has proven highly
sensitive in detecting atherosclerotic plaques, there is a
limitation to its spatial resolution, which makes it hazard-
ous to assess very small plaques, in particular if located
distally in the coronary arteries [33]. The carotid ultra-
sound examination focused on the IMT of the common
carotid artery, whereas additional analyses such as plaque
detection might have yielded different results. Indeed,
plaque assessment of the carotid arteries, including the
carotid bulb and the internal carotid artery, has been
shown to predict CAD and outcome better than IMT
alone [14]. Similarly, the choice of RH-PAT, in order to
ensure a highly reproducible method for measuring
endothelial function, instead of for instance brachial ar-
tery flow mediated dilation might also have affected the
results. It has been shown that different risk factors
affect endothelial function of the microvasculature (as
measured with RH-PAT) and the conduit vessels differ-
ently [34]. Another factor influencing our results might
be the fact that endothelial function was determined
with one single test. Repeated measurement has been
proposed in order to augment accuracy, since endothe-
lial function is a dynamic process, which can be transi-
ently affected by a variety of factors [29]. Importantly, our
study did not examine the prognostic value of RH-PAT or
IMT.
The contradictory findings of various studies may in
part be related to differences of the study groups, with
highly variable prevalences of risk factors and CVD.
Another important issue is the choice of methods, as
discussed above. One explanation for the lack of associ-
ation between IMT or endothelial function and CAD
demonstrated in this study might be the fact that the
different measures reflect the presence of different under-
lying cardiovascular risk factors, to which the various vas-
cular beds are more or less susceptible. Notably, Bauer et
al. demonstrated that certain risk factors have different
impacts on IMT and CAC, with diabetes having a rela-
tively higher impact on IMT and blood pressure showing
the strongest association with CAC [35]. In some studies
endothelial dysfunction has been shown to precede the
appearance of CAD or to predict the progression of IMT,
hence suggesting that it represents an earlier step in the
atherosclerotic process [36, 37]. Our results, however, do
not entirely support this hypothesis, since a large number
of subjects with CAD evident by coronary CTA displayed
a normal endothelial function.
Conclusions
Our results suggest that neither measurement of periph-
eral endothelial function by RH-PAT nor carotid ultra-
sound assessment of IMT alone can reliably be used to
predict subclinical coronary atherosclerosis, as determined
by coronary CTA.
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